{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:58:12Z","timestamp":1791374292187,"version":"4.3.1"},"reference-count":99,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Kazan Federal University Strategic Academic Leadership Program","award":["Priority-2030"],"award-info":[{"award-number":["Priority-2030"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Radiation therapy or radiotherapy is a medical treatment that uses high doses of ionizing radiation to eliminate cancer cells and shrink tumors. It works by targeting the DNA within the tumor cells restricting their proliferation. Radiotherapy has been used for treating cancer for more than 100 years. Along with surgery and chemotherapy, it is one of the three main and most common approaches used in cancer therapy. Nowadays, radiotherapy has become a standard treatment option for a wide range of cancers around the world, including lung, breast, cervical, and colorectal cancers. Around 50% of all patients will require radiotherapy, 60% of whom are treated with curative intent. Moreover, it is commonly used for palliative treatment. Radiotherapy provides 5-year local control and overall survival benefit in 10.4% and 2.4% of all cancer patients, respectively. The highest local control benefit is reported for cervical (33%), head and neck (32%), and prostate (26%) cancers. But no benefit is observed in pancreas, ovary, liver, kidney, and colon cancers. Such relatively low efficiency is related to the development of radiation resistance, which results in cancer recurrence, metastatic dissemination, and poor prognosis. The identification of radioresistance biomarkers allows for improving the treatment outcome. These biomarkers mainly include proteins involved in metabolism and cell signaling pathways.<\/jats:p>","DOI":"10.3390\/diseases13010022","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T10:27:58Z","timestamp":1737109678000},"page":"22","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Resistance to Radiotherapy in Cancer"],"prefix":"10.3390","volume":"13","author":[{"given":"Almaz A.","family":"Akhunzianov","sequence":"first","affiliation":[{"name":"Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira V.","family":"Rozhina","sequence":"additional","affiliation":[{"name":"Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1853-8365","authenticated-orcid":false,"given":"Yuliya V.","family":"Filina","sequence":"additional","affiliation":[{"name":"Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9427-5739","authenticated-orcid":false,"given":"Albert A.","family":"Rizvanov","sequence":"additional","affiliation":[{"name":"Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia"},{"name":"Division of Medical and Biological Sciences, Tatarstan Academy of Sciences, 420111 Kazan, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6686-1968","authenticated-orcid":false,"given":"Regina R.","family":"Miftakhova","sequence":"additional","affiliation":[{"name":"Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nrc2587","article-title":"Normal tissue reactions to radiotherapy: Towards tailoring treatment dose by genotype","volume":"9","author":"Barnett","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.radonc.2017.11.004","article-title":"The population benefit of evidence-based radiotherapy: 5-Year local control and overall survival benefits","volume":"126","author":"Hanna","year":"2018","journal-title":"Radiother. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.radonc.2016.02.016","article-title":"How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis","volume":"119","author":"Borras","year":"2016","journal-title":"Radiother. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1148\/79.5.829","article-title":"The Development and Organization of Therapeutic Radiology in Sweden","volume":"79","author":"Berven","year":"1962","journal-title":"Radiology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3747\/co.2007.120","article-title":"Priority for radium therapy of benign conditions and cancer","volume":"14","author":"Mould","year":"2007","journal-title":"Curr. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.canrad.2016.08.123","article-title":"L\u2019aube de la radioth\u00e9rapie, entre coups de g\u00e9nie, drames et controverses","volume":"20","author":"Cosset","year":"2016","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"ref_8","first-page":"e69371","article-title":"Henri Coutard (1876\u20131950): A Pioneer of Fractionated Radiotherapy Regimens","volume":"16","author":"Prakash","year":"2024","journal-title":"Cureus."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3109\/02841869509127225","article-title":"Development of clinical radiotherapy since 1896","volume":"34","author":"Holsti","year":"1995","journal-title":"Acta Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrurol.2013.185","article-title":"Evolution of advanced technologies in prostate cancer radiotherapy","volume":"10","author":"Zaorsky","year":"2013","journal-title":"Nat. Rev. Urol."},{"key":"ref_11","first-page":"75","article-title":"Clinical applications of cone-beam computed tomography in dental practice","volume":"72","author":"Scarfe","year":"2006","journal-title":"J.-Can. Dent. Assoc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1088\/0031-9155\/48\/3\/302","article-title":"Determination of beam intensity in a single step for IMRT inverse planning","volume":"48","author":"Chuang","year":"2003","journal-title":"Phys. Med. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ejca.2013.11.027","article-title":"New radiotherapy approaches in locally advanced non-small cell lung cancer","volume":"50","author":"Christodoulou","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrurol.2017.76","article-title":"The evolution of brachytherapy for prostate cancer","volume":"14","author":"Zaorsky","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1111\/iju.15051","article-title":"Local dose (biologically effective dose \u2265 180\u2009Gy2) is an important predictor of biochemical recurrence in patients undergoing low-dose-rate brachytherapy","volume":"29","author":"Tanaka","year":"2022","journal-title":"Int. J. Urol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semradonc.2019.08.002","article-title":"Progress in Low Dose Rate Brachytherapy for Prostate Cancer","volume":"30","author":"McLaughlin","year":"2020","journal-title":"Semin. Radiat. Oncol."},{"key":"ref_17","first-page":"207","article-title":"[General remarks on brachytherapy]","volume":"65","author":"Nishio","year":"2005","journal-title":"Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.canrad.2022.08.007","article-title":"Comparison between the HyperArc\u2122 technique and the CyberKnife\u00ae technique for stereotactic treatment of brain metastases","volume":"27","author":"Guinement","year":"2023","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"ref_19","first-page":"61","article-title":"Intracranial stereotactic radiosurgery","volume":"63","author":"Fanous","year":"2019","journal-title":"J. Neurosurg. Sci."},{"key":"ref_20","first-page":"265","article-title":"IMRT, IGRT, SBRT Advances in the treatment planning and delivery of radiotherapy","volume":"2","author":"Kubicky","year":"2011","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Hughes, J.R., and Parsons, J.L. (2020). FLASH Radiotherapy: Current Knowledge and Future Insights Using Proton-Beam Therapy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186492"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5603\/RPOR.a2022.0038","article-title":"FLASH radiotherapy: An emerging approach in radiation therapy","volume":"27","author":"Matuszak","year":"2022","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Marcu, L.G., Bezak, E., Peukert, D.D., and Wilson, P. (2021). Translational Research in FLASH Radiotherapy-From Radiobiological Mechanisms to In Vivo Results. Biomedicines, 9.","DOI":"10.3390\/biomedicines9020181"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1002\/mp.15642","article-title":"3D computational model of oxygen depletion kinetics in brain vasculature during FLASH RT and its implications for in vivo oximetry experiments","volume":"49","author":"Cui","year":"2022","journal-title":"Med. Phys."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/09553002.2021.2004328","article-title":"Understanding the FLASH effect to unravel the potential of ultra-high dose rate irradiation","volume":"98","author":"Kacem","year":"2022","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2019.06.019","article-title":"Treatment of a first patient with FLASH-radiotherapy","volume":"139","author":"Bourhis","year":"2019","journal-title":"Radiother. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jamaoncol.2022.5843","article-title":"Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases: The FAST-01 Nonrandomized Trial","volume":"9","author":"Mascia","year":"2023","journal-title":"JAMA Oncol."},{"key":"ref_28","first-page":"100743","article-title":"Randomized phase II selection trial of FLASH and conventional radiotherapy for patients with localized cutaneous squamous cell carcinoma or basal cell carcinoma: A study protocol","volume":"45","author":"Kinj","year":"2024","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"245ra293","DOI":"10.1126\/scitranslmed.3008973","article-title":"Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice","volume":"6","author":"Favaudon","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"10943","DOI":"10.1073\/pnas.1901777116","article-title":"Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species","volume":"116","author":"Acharya","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/cncr.21324","article-title":"The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines","volume":"104","author":"Delaney","year":"2005","journal-title":"Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"vi7","DOI":"10.1093\/annonc\/mdt284","article-title":"Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Senkus","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.clon.2015.06.002","article-title":"Biomarkers of Tumour Radiosensitivity and Predicting Benefit from Radiotherapy","volume":"27","author":"Forker","year":"2015","journal-title":"Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"100024","DOI":"10.1016\/j.nucana.2022.100024","article-title":"Radiation target: Moving from theory to practice","volume":"1","author":"Li","year":"2022","journal-title":"Nucl. Anal."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/j.seminoncol.2021.05.002","article-title":"Implications of reactive oxygen species on cancer formation and its treatment","volume":"48","author":"Shah","year":"2021","journal-title":"Semin. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Maier, P., Hartmann, L., Wenz, F., and Herskind, C. (2016). Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17010102"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/09553002.2014.892227","article-title":"Cancer stem cells and radioresistance","volume":"90","author":"Rycaj","year":"2014","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1200\/JCO.2009.22.3701","article-title":"Clinical trial designs for predictive biomarker validation: Theoretical considerations and practical challenges","volume":"27","author":"Mandrekar","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0360-3016(00)01488-7","article-title":"Head and neck cancer as a clinical model for molecular targeting of therapy: Combining EGFR blockade with radiation","volume":"49","author":"Harari","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0022-2828(03)00242-6","article-title":"How glucose and glucose transporters protect cardiac myocytes","volume":"35","author":"Brosius","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.oraloncology.2006.10.009","article-title":"Overexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity","volume":"43","author":"Kunkel","year":"2007","journal-title":"Oral Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1089\/ars.2006.8.1273","article-title":"Mn-superoxide dismutase overexpression enhances G2 accumulation and radioresistance in human oral squamous carcinoma cells","volume":"8","author":"Kalen","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"108","DOI":"10.21037\/atm.2019.12.114","article-title":"Building radiation-resistant model in triple-negative breast cancer to screen radioresistance-related molecular markers","volume":"8","author":"Zhou","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1042\/bst0311143","article-title":"Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation","volume":"31","author":"Holness","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1667\/RR3401","article-title":"Identification of Differentially Expressed Genes Contributing to Radioresistance in Lung Cancer Cells using Microarray Analysis","volume":"164","author":"Guo","year":"2005","journal-title":"Radiat. Res."},{"key":"ref_46","first-page":"585","article-title":"Role of inhibitor of apoptosis protein Livin in radiation resistance in nonsmall cell lung cancer","volume":"26","author":"Sun","year":"2011","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ijrobp.2009.12.076","article-title":"Differential gene expression profiles of radioresistant non-small-cell lung cancer cell lines established by fractionated irradiation: Tumor protein p53-inducible protein 3 confers sensitivity to ionizing radiation","volume":"77","author":"Lee","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","article-title":"HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption","volume":"3","author":"Papandreou","year":"2006","journal-title":"Cell Metab."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00280-016-3007-9","article-title":"Inhibition of Glut1 by WZB117 sensitizes radioresistant breast cancer cells to irradiation","volume":"77","author":"Zhao","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: The metabolic requirements of cell proliferation","volume":"324","author":"Cantley","year":"2009","journal-title":"Science"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.celrep.2013.07.023","article-title":"Obesity promotes liver carcinogenesis via Mcl-1 stabilization independent of IL-6R\u03b1 signaling","volume":"4","author":"Gruber","year":"2013","journal-title":"Cell Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.radonc.2014.07.015","article-title":"AKT-mediated enhanced aerobic glycolysis causes acquired radioresistance by human tumor cells","volume":"112","author":"Shimura","year":"2014","journal-title":"Radiother. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Bhatt, A.N., Chauhan, A., Khanna, S., Rai, Y., Singh, S., Soni, R., Kalra, N., and Dwarakanath, B.S. (2015). Transient elevation of glycolysis confers radio-resistance by facilitating DNA repair in cells. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1368-9"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Galochkina, T., Ng Fuk Chong, M., Challali, L., Abbar, S., and Etchebest, C. (2019). New insights into GluT1 mechanics during glucose transfer. Sci. Rep., 9.","DOI":"10.1038\/s41598-018-37367-z"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cell.2005.07.032","article-title":"Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2","volume":"123","author":"Nutt","year":"2005","journal-title":"Cell"},{"key":"ref_58","first-page":"1651","article-title":"Co-expression of CD147 and GLUT-1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma","volume":"7","author":"Huang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Wang, X., Shen, X., Yan, Y., and Li, H. (2021). Pyruvate dehydrogenase kinases (PDKs): An overview toward clinical applications. Biosci. Rep., 41.","DOI":"10.1042\/BSR20204402"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1158\/1535-7163.MCT-15-0247","article-title":"Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism","volume":"14","author":"Shen","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ajpath.2011.05.050","article-title":"Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer","volume":"179","author":"Lu","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.canlet.2014.11.016","article-title":"Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo","volume":"356","author":"Meng","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.3892\/mmr.2015.4233","article-title":"Apigenin inhibits the proliferation of adenoid cystic carcinoma via suppression of glucose transporter-1","volume":"12","author":"Fang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.yexcr.2010.02.028","article-title":"HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells","volume":"316","author":"Liu","year":"2010","journal-title":"Exp. Cell Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.molcel.2016.02.011","article-title":"Mitochondria and Cancer","volume":"61","author":"Zong","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1089\/ars.2013.5305","article-title":"MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx","volume":"20","author":"Candas","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4161\/cbt.7.8.6300","article-title":"Mitochondria-targeted antioxidant enzyme activity regulates radioresistance in human pancreatic cancer cells","volume":"7","author":"Fisher","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"ref_68","first-page":"5382","article-title":"Overexpression of mitochondrial manganese superoxide dismutase protects against radiation-induced cell death in the human hepatocellular carcinoma cell line HLE","volume":"61","author":"Motoori","year":"2001","journal-title":"Cancer Res."},{"key":"ref_69","first-page":"137","article-title":"Role of reactive oxygen species in cells overexpressing manganese superoxide dismutase: Mechanism for induction of radioresistance","volume":"1","author":"Takada","year":"2002","journal-title":"Mol. Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01275210","article-title":"Effects of ionizing radiation on cell cycle progression. A review","volume":"34","author":"Bernhard","year":"1995","journal-title":"Radiat. Environ. Biophys."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e997518","DOI":"10.1080\/23723556.2014.997518","article-title":"MKP1 mediates resistance to therapy in HER2-positive breast tumors","volume":"2","author":"Candas","year":"2015","journal-title":"Mol. Cell. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1148\/114.1.199","article-title":"Cell cycle redistribution as a factor in multifraction irradiation","volume":"114","author":"Withers","year":"1975","journal-title":"Radiology"},{"key":"ref_73","first-page":"387","article-title":"Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer","volume":"6","author":"Palmer","year":"2014","journal-title":"J. Thorac. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1158\/0008-5472.CAN-04-3995","article-title":"Lost in transcription: p21 repression, mechanisms, and consequences","volume":"65","author":"Gartel","year":"2005","journal-title":"Cancer Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2016.02.002","article-title":"Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments","volume":"109","author":"Krause","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature07733","article-title":"Association of reactive oxygen species levels and radioresistance in cancer stem cells","volume":"458","author":"Diehn","year":"2009","journal-title":"Nature"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1158\/0008-5472.CAN-14-0626","article-title":"Distinct subpopulations of head and neck cancer cells with different levels of intracellular reactive oxygen species exhibit diverse stemness, proliferation, and chemosensitivity","volume":"74","author":"Chang","year":"2014","journal-title":"Cancer Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.radonc.2013.06.003","article-title":"Discovery of the cancer stem cell related determinants of radioresistance","volume":"108","author":"Peitzsch","year":"2013","journal-title":"Radiother. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.phrs.2018.10.011","article-title":"Therapy-induced enrichment of cancer stem-like cells in solid human tumors: Where do we stand?","volume":"137","author":"Gomes","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Arechaga-Ocampo, E., Lopez-Camarillo, C., Ramos-Suzarte, M., and Gonzalez-De la Rosa, C. (2013). Biomarkers in Lung Cancer: Integration of Genomics with Radiotherapy Response Data, IntechOpen.","DOI":"10.5772\/53426"},{"key":"ref_81","first-page":"993","article-title":"MDM2, an introduction","volume":"1","author":"Iwakuma","year":"2003","journal-title":"Mol. Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.canrad.2016.05.013","article-title":"Prognostic significance of Livin expression in nasopharyngeal carcinoma after radiotherapy","volume":"20","author":"Liu","year":"2016","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1097-2765(02)00482-3","article-title":"Mechanisms of caspase activation and inhibition during apoptosis","volume":"9","author":"Shi","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1158\/0008-5472.CAN-03-3547","article-title":"Survivin As a Therapeutic Target for Radiation Sensitization in Lung Cancer","volume":"64","author":"Lu","year":"2004","journal-title":"Cancer Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.2147\/OTT.S166798","article-title":"Inhibition of survivin enhances radiosensitivity of esophageal cancer cells by switching radiation-induced senescence to apoptosis","volume":"11","author":"Liu","year":"2018","journal-title":"OncoTargets Ther."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/21655979.2020.1717297","article-title":"Targeting survivin sensitizes cervical cancer cells to radiation treatment","volume":"11","author":"Zhou","year":"2020","journal-title":"Bioengineered"},{"key":"ref_87","first-page":"2678","article-title":"Survivin silencing enhances radiosensitivity in oral squamous cell carcinoma cell","volume":"18","author":"Sun","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/jnci\/84.8.622","article-title":"Differential expression of proteins in radioresistant and radiosensitive human squamous carcinoma cells","volume":"84","author":"Ramsamooj","year":"1992","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_89","first-page":"885","article-title":"Local recurrence in head and neck cancer: Relationship to radiation resistance and signal transduction","volume":"8","author":"Gupta","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0360-3016(03)00511-X","article-title":"The epidermal growth factor receptor mediates radioresistance","volume":"57","author":"Liang","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1200\/JCO.2003.10.044","article-title":"Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents","volume":"21","author":"Ma","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0360-3016(03)00214-1","article-title":"Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002","volume":"56","author":"Gupta","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/gcc.10296","article-title":"Targeting tumor cells by enhancing radiation sensitivity","volume":"38","author":"McKenna","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Li, K., Zhu, X., Li, L., Ning, R., Liang, Z., Zeng, F., Su, F., Huang, S., Yang, X., and Qu, S. (2020). Identification of non-invasive biomarkers for predicting the radiosensitivity of nasopharyngeal carcinoma from serum microRNAs. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-61958-4"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5893981","DOI":"10.1155\/2021\/5893981","article-title":"Circulating Exosomal miR-96 as a Novel Biomarker for Radioresistant Non-Small-Cell Lung Cancer","volume":"2021","author":"Zheng","year":"2021","journal-title":"J. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"32707","DOI":"10.18632\/oncotarget.9017","article-title":"Extracellular miR-1246 promotes lung cancer cell proliferation and enhances radioresistance by directly targeting DR5","volume":"7","author":"Yuan","year":"2016","journal-title":"Oncotarget"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/JTO.0b013e3182152ba6","article-title":"Baseline Plasma Proteomic Analysis to Identify Biomarkers that Predict Radiation-Induced Lung Toxicity in Patients Receiving Radiation for Non-small Cell Lung Cancer","volume":"6","author":"Cai","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"ref_98","first-page":"CD007583","article-title":"Radiotherapy and chemoradiation after surgery for early cervical cancer","volume":"2012","author":"Rogers","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1177\/0300060517709614","article-title":"Plasma miR-145 as a novel biomarker for the diagnosis and radiosensitivity prediction of human cervical cancer","volume":"45","author":"Wei","year":"2017","journal-title":"J. Int. Med. Res."}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/1\/22\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:30:54Z","timestamp":1759919454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/1\/22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["diseases13010022"],"URL":"https:\/\/doi.org\/10.3390\/diseases13010022","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]}}}